Douglas Throckmorton, M.D., Deputy Center Director for Regulatory Programs

As the Deputy Center Director for Regulatory Programs in CDER, Doug Throckmorton shares responsibility for overseeing the regulation of research, development, manufacture and marketing of prescription, over-the-counter, and generic drugs in the United States. From aspirin to cancer-treatments, CDER works to ensure that the benefits of approved drug products outweigh their known risks.

Dr. Throckmorton is Board-certified in internal medicine and nephrology, having received his training at the University of Nebraska Medical School, Case Western Reserve University, and Yale University.  Before coming to FDA, he practiced medicine at the Medical College of Georgia in Augusta Georgia.